[August 11, 2011] Verinata Health Secures $48.5 Million in Additional Funding Tweet Aug 12, 2011 (Close-Up Media via COMTEX) -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, announced that it has raised approximately $46.5 million in the finalization of its Series C financing with the remaining $2.0 million expected to close on August 31. The Company said the funding was led by existing investors Mohr Davidow Ventures, Sutter Hill Ventures, and Alloy Ventures. Verinata plans to use the proceeds to fund continued research and development and subsequent commercialization of its non-invasive prenatal diagnostic test. "This substantial financing demonstrates our investors' confidence in Verinata's ability to meet or exceed corporate and product milestones as we proceed rapidly on the path to commercialization of our first diagnostic test," said Caren L. Mason, chief executive officer of Verinata Health. "We look forward to completing our validation study later this calendar year, as we prepare for a successful launch of our non-invasive prenatal diagnostic in the first quarter of 2012." Verinata: verinata.com ((Comments on this story may be sent to [email protected])) [ Back To TMCnet.com's Homepage ]